Accumulating studies suggest that endocan has been involved in angiogenesis, endothelial dysfunction, and inflammation, and accordingly, changes of circulating endocan has been observed in patients with cardiovascular diseases, including hypertension [14–16]. This evidence concerns the gene ESM1 and hypertensive disorder.